Express Scripts, a leading pharmacy-benefits manager, is expected to propose buying Caremark Rx for $26 billion in cash and stock, as part of an effort to block a CVS Corp. takeover of Caremark. The proposal expected to be announced today likely will focus on cost-savings in the distribution process, an area that insurers and the government are trying to squeeze.

Related Summaries